pennsylvania biotechnology center photobanner

Seminar Series Schedule 2009

An annual Seminar Series is co-sponsored by the Institute for Hepatitis and Virus Research (IHVR), the Hepatitis B Foundation, and the Drexel Institute to promote scientific exchange at the national and international level.

January 8 - 11:00 AM - Chuck Reynolds, PhD (Johnson & Johnson)
"Application of Computer Modeling in Drug Discovery"

January 30 - 11:00 AM - Yvonne Paterson, PhD (Dept. of Microbiology, University of Pennsylvania School of Medicine)
"A Multi-pronged Approach to Tumor Immunotherapy Using Listeria Monocytogenes as an Antigen Delivery Vehicle"

February 13 - 11:00 AM - Sandhya Kortagers, PhD (Microbiology and Immunology, Drexel University College of Medicine)
"Hybrid Structure Based Method and its Application to Design New Lead Compounds"

March 3 - 11:00 AM - Brian Haab, PhD (Laboratory of Cancer Immunodiagnostics, Van Andel Institute)
"The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Glycan Sandwich Arrays"

March 11 - 11:00 AM - Wai Law, PhD (PortaScience, Inc.)
"Point-of-Care Testing for WBCs"

March 11 - 3:00 PM - Nathalie Scholler, MD, PhD (Obstetrics and Gynecology, University of Pennsylvania School of Medicine)
"Biobody Technology"

March 16 - 11:00 AM - Raj Mutharason, PhD (Chemical and Biological Engineering, Drexel University)
"Piezoelectric-Excited Millimeter-Sized Cantilever (PEMC) Sensors for Detecting Pathogens and Biomarkers at Femtogram Levels"

March 19 - 4:00 PM - Dr. Stephen Locarnini (Victorian Infectious Diseases Reference Laboratory / WHO Collaborating Centre for Virus Reference & Research)
The Virology of Hepatitis B Immunomodulation and Therapy"
Hepatitis B Foundation's 2009 Bruce Witte Lecturer

March 25 - 11:00 AM - Dr. Wolfram Gerlich (Institute for Medical Virology, Geissen, Germany)
"Escape Mutants in Occult and Reactivated Hepatitis B Virus Infection"

April 8 - 11:00 AM - Dr. Harvey Friedman (Infectious Disease Division, University of Pennsylvania School of Medicine)
"Translating Basic Discoveries of HSV-2 Pathogenesis Into an HSV-2 Vaccine"

April 16 - 11:00 AM - Paul Ahlquist, PhD (Institute for Molecular Virology, University of Wisconsin)
"Viral and Host Functions in RNA and Reverse-Transcribing Virus Replication"

April 27 - 11:00 AM - Raymond Dwek, FRS (Oxford Glycobiology Institute, University of Oxford)
"Glycobiology - Leading to Novel Therapies for Hepatitis and HIV"

May 20 - 11:00 AM - Dr. David Kaplan (Gastroenterology Division, University of Pennsylvania School of Medicine)
"Dysfunctional Tumor Antigen-Specific T-Cell Responses in Hepatocellular Carcinoma"

May 27 - 11:00 AM - Bart DeCorte, PhD (Pharmaceutical Research & Development, Johnson & Johnson)
"The Long Road to Intelence®, a Next-Generation NNRTI for the Treatment of HIV"

June 17 - 11:00 AM - Terry Butters, PhD (Glycobiology Institute, University of Oxford)
"Therapeutic Potential of Protein Folding Inhibitors"

June 26 - 11:00 AM - Dr. Michael Fried (University of North Carolina at Chapel Hill)
"HBV Treatment Guidelines: Navigating the Twilight Zone"

July 16 - 11:00 AM - Gary Jacob, PhD (Synergy Pharmaceuticals, Inc.)
"What a Lifetime in Drug Development Has Taught Me... Or, What They Don't Teach you in Graduate School"

August 19 - 11:00 AM - Stephen Lee, PhD (OraSure Technologies, Inc.)
"Recent Developments in Point of Care Testing for HIV and Hepatitis"

September 16 - 11:00 AM - Bruce Maryanoff, PhD (Johnson & Johnson Pharmaceutical Research & Development)
"An Odyssey in Drug Discovery Through Serine-Protease Space"

September 18 - 8:30 AM - 2009 Annual Regional Biotech Conference*
"A Roadmap for Biotechnology Ventures"

September 23 - 11:00 AM - Luis Montaner, DVM (The Wistar Institute)
"Innate Immune Effectors and HIV-1: From Viral Replication to ART and Back"

September 30 - 11:00 AM - James Arthos, PhD (Laboratory of Immunoregulation, NIAID, NIH)
"The Role of Integrin Alpha4beta7 in HIV-1 Transmission"

October 5 - 11:00 AM - James Barrett, PhD (Drexel University College of Medicine)
"Development of Drugs to Treat Cognitive Disorders Associated with Psychiatric and Neurological Diseases"

October 15 - 11:00 AM - Daniel Flynn, PhD (Commonwealth Medical College)
"Defining the Cellular Function of AFAP1: A Potential Drug Target for Breast and Ovarian Cancer "

October 21 - 11:00 AM - Rene Daniel, MD, PhD (Thomas Jefferson University, Jefferson Medical College)
"Epigenetics in Gene Transfer and Stem Cell Differentiation"

October 29 - 11:00 AM - Hie-Won Hann, MD (Thomas Jefferson University, Jefferson Medical College)
"Antiviral Therapy for Hepatitis B and Hepatocellular Carcinoma"

November 2 - 11:00 AM - Maria Maccecchini, PhD (President & CEO, QR Pharma)*
"Pathways Leading to Alzheimer's Disease"

November 12 - 11:00 AM - D. Craig Hooper, PhD (WHO Center for Neurovirology, Thomas Jefferson University)"Delivery of Therapeutics Across the Blood-Brain Barrier by Immune Mechanisms"

November 19 - 4:00 PM - Allen Reitz, PhD (ALS BioPharma)*
"The Pennsylvania Center for Drug Discovery: Public Private Partnerships to Accelerate Innovation"

November 30 - 11:00 AM - Melik Demirel, PhD (Penn State University)
"Pathogen Sensing Via Ramen Activated Nanoparticles (RANs)"

December 17 - 11:00 AM - Lin Li, PhD (University of Pennsylvania)
"Novel Biomarkers of Cancer Metastatic Potential by MR/Optical Imaging"

December 21 - 4:00 PM - Herb Taylor, PhD (VP, Federal Reserve Bank of Philadelphia)*
"Outlook For The U.S. Economy"


*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)

**PA Center for Drug Discovery Seminar Speakers

Hepatitis B Foundation
delaware college